New ADA 2026 data show diabetic ketoacidosis hospitalizations rising 24%, driven by poor ketone monitoring and symptom recognition gaps across all ages. A key driver of that burden is recognition—or ...
Abbott (NYSE:ABT) today announced new clinical data highlighting the importance of managing diabetic ketoacidosis (DKA).
Not all patients in the emergency department diagnosed with diabetic ketoacidosis meet laboratory criteria; a study shows that physicians rely on clinical signs and symptoms.
Having multiple readmissions for diabetes ketoacidosis (DKA) was more likely to occur among patients with type 1 diabetes (T1D) with substance use disorder or who previously were incarcerated.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results